Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide + Capecitabine for Locally Advanced Rectal Cancer
NCT03156036Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Nov 2017
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of temozolomide in rectal cancer, sponsored by Asan Medical Center. Started Nov 2017; status: completed.
02
Drugs
temozolomide
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03156036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03156036.